Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clyde W Yancy

Showing results (61-70 of 644) with videos related to

Pageof 65
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|February 12, 2004
The natural history, epidemiology, and prognosis of heart failure in African AmericansClyde W Yancy, Mark Strong
Congestive Heart Failure (Greenwich, Conn.)|February 12, 2004
Summary: Cardiovascular disease in African AmericansClyde W Yancy, Ronald Victor
Clinical and Translational Science|May 7, 2010
Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?Clyde W Yancy, Arthur Feldman
Journal of the American College of Cardiology|November 26, 2016
Reply: Why to Replace an ACE or ARB With an ARB/Neprilysin Inhibitor?Clyde W Yancy, Mariell Jessup
Heart Failure Clinics|November 20, 2018
Heart Failure with Preserved Ejection Fraction in WomenAnjan Tibrewala, Clyde W Yancy
JACC. Heart Failure|February 8, 2023
Sociodemographic Disparities in the GDMT UsagePurvi Parwani, Clyde W Yancy
JAMA Cardiology|December 6, 2023
Race, Racism, and Risk-Implications of Social Determinants of Health in Cardiovascular Disease PredictionSadiya S Khan, Clyde W Yancy
JAMA Cardiology|March 12, 2018
The TREAT Trial-Moving ST-Elevation Myocardial Infarction Care Forward, With More to DoClyde W Yancy, Robert A Harrington
Vascular Health and Risk Management|February 28, 2007
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failureMelvin R Echols, Clyde W Yancy
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2004
Cardiovascular disease in African AmericansClyde W Yancy, Domenic A Sica
Pageof 65

Showing results (61-70 of 644) with videos related to

Sort By:
Pageof 65
Congestive Heart Failure (Greenwich, Conn.)|February 12, 2004
The natural history, epidemiology, and prognosis of heart failure in African AmericansClyde W Yancy, Mark Strong
Congestive Heart Failure (Greenwich, Conn.)|February 12, 2004
Summary: Cardiovascular disease in African AmericansClyde W Yancy, Ronald Victor
Clinical and Translational Science|May 7, 2010
Isosorbide dinitrate and hydralazine as therapy for African Americans with heart failure; a failed paradigm?Clyde W Yancy, Arthur Feldman
Journal of the American College of Cardiology|November 26, 2016
Reply: Why to Replace an ACE or ARB With an ARB/Neprilysin Inhibitor?Clyde W Yancy, Mariell Jessup
Heart Failure Clinics|November 20, 2018
Heart Failure with Preserved Ejection Fraction in WomenAnjan Tibrewala, Clyde W Yancy
JACC. Heart Failure|February 8, 2023
Sociodemographic Disparities in the GDMT UsagePurvi Parwani, Clyde W Yancy
JAMA Cardiology|December 6, 2023
Race, Racism, and Risk-Implications of Social Determinants of Health in Cardiovascular Disease PredictionSadiya S Khan, Clyde W Yancy
JAMA Cardiology|March 12, 2018
The TREAT Trial-Moving ST-Elevation Myocardial Infarction Care Forward, With More to DoClyde W Yancy, Robert A Harrington
Vascular Health and Risk Management|February 28, 2007
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failureMelvin R Echols, Clyde W Yancy
Journal of Clinical Hypertension (Greenwich, Conn.)|April 10, 2004
Cardiovascular disease in African AmericansClyde W Yancy, Domenic A Sica
Pageof 65